With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but a bane for exporters.

Key Findings from the RAG-17 IIT Study Presented at AAN 2025: The final data from the IIT (NCT05903690), a first-in-human, open-label, dose-escalation study involving six SOD1-ALS patients over 240 ...

A jury led by Hungarian director, screenwriter, and producer Béla Tarr will judge the 15-movie strong Forward Future section ...

Tiantan [SHA: 600161], one of China’s largest blood product suppliers, closed up 6.4 percent at CNY22.02 (USD3). Rival ...